Establishment and Image based evaluation of a New Preclinical Rat Model of Osteoblastic Bone Metastases

Clin Exp Metastasis. 2022 Oct;39(5):833-840. doi: 10.1007/s10585-022-10175-6. Epub 2022 Jul 11.

Abstract

Bone remodeling is disrupted in the presence of metastases and can present as osteolytic, osteoblastic or a mixture of the two. Established rat models of osteolytic and mixed metastases have been identified changes in structural and tissue-level properties of bone. The aim of this work was to establish a preclinical rat model of osteoblastic metastases and characterize bone quality changes through image-based evaluation. Female athymic rats (n = 22) were inoculated with human breast cancer cells ZR-75-1 and tumor development tracked over 3-4 months with bioluminescence and in-vivo µCT imaging. Bone tissue-level stereological features were quantified on ex-vivo µCT imaging. Histopathology verified the presence of osteoblastic bone. Bone mineral density distribution was assessed via backscattered electron microscopy. Newly formed osteoblastic bone was associated with reduced mineral content and increased heterogeneity leading to an overall degraded bone quality. Characterizing changes in osteoblastic bone properties is relevant to pre-clinical therapeutic testing and treatment planning.

Keywords: Bone tissue level properties; In-vivo imaging; Osteoblastic bone metastases; Rat model.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Density
  • Bone Neoplasms* / pathology
  • Bone Remodeling
  • Bone and Bones
  • Female
  • Humans
  • Osteoblasts / metabolism
  • Rats
  • Rats, Nude

Grants and funding